BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1441334)

  • 1. [The sterility of blood products manufactured in Ukraine].
    Liubich VV
    Lik Sprava; 1992 Feb; (2):57-60. PubMed ID: 1441334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors determining quality of plasma.
    Myllylä G
    Vox Sang; 1998; 74 Suppl 2():507-11. PubMed ID: 9704491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bacterial contamination in blood and blood products].
    Sertöz RY; Aydemir S; Uysal A; Tünger A; Aydinok Y
    Mikrobiyol Bul; 2005 Jan; 39(1):79-82. PubMed ID: 15900840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European project concerning the guidelines on medicinal products derived from human blood and plasma.
    Horaud F
    Dev Biol Stand; 1991; 75():237-40. PubMed ID: 1794627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. United States Department of Agriculture: requirements for sterility testing veterinary biologics.
    Koski TA
    Dev Biol Stand; 1974; 23():169-73. PubMed ID: 4459192
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacterial contamination of blood and blood components in three major blood transfusion centers, Accra, Ghana.
    Adjei AA; Kuma GK; Tettey Y; Ayeh-Kumi PF; Opintan J; Apeagyei F; Ankrah JO; Adiku TK; Narter-Olaga EG
    Jpn J Infect Dis; 2009 Jul; 62(4):265-9. PubMed ID: 19628902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of bacterial contamination in blood and blood products at the National Blood Service Zimbabwe.
    Makuni N; Simango C; Mavenyengwa RT
    J Infect Dev Ctries; 2015 Apr; 9(4):421-4. PubMed ID: 25881533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term analysis of sterility testing of immunobiological preparations.
    Winkler D; Lukaszewicz V
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):317-22. PubMed ID: 2809187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of the scan statistic for quality control in blood product manufacturing.
    Lachenbruch PA; Foulkes MA; Williams AE; Epstein JS
    J Biopharm Stat; 2005; 15(2):353-66. PubMed ID: 15796300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide perspective in transfusion safety: Europe.
    Reesink HW; Strengers PE
    Dev Biol (Basel); 2000; 102():205-10. PubMed ID: 10794107
    [No Abstract]   [Full Text] [Related]  

  • 11. The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS.
    Mahony BO; Turner A
    Vox Sang; 2010 Apr; 98(3 Pt 2):447-50. PubMed ID: 20158697
    [No Abstract]   [Full Text] [Related]  

  • 12. Reducing the risk of bacterial contamination of cellular blood components.
    Blajchman MA
    Dev Biol (Basel); 2000; 102():183-93. PubMed ID: 10794105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety monitoring and epidemiological surveillance of blood transfusion in the United States.
    Menache D; O'Malley JP
    Transfus Clin Biol; 1995; 2(1):7-12. PubMed ID: 7728271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sterility testing of immunological products: comparative efficacy of media and effect of preservatives.
    Thornton DH; Maley AD; Frerichs GN
    J Biol Stand; 1987 Apr; 15(2):117-26. PubMed ID: 3597447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral safety concept: application to blood and blood products].
    Trouvin JH
    Rev Prat; 2005 Nov; 55(18):2033-8. PubMed ID: 16419908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and public perception.
    Allain JP
    Dev Biol (Basel); 2000; 102():229-35. PubMed ID: 10794111
    [No Abstract]   [Full Text] [Related]  

  • 17. Removal of TSE agents from blood products.
    Foster PR
    Vox Sang; 2004 Jul; 87 Suppl 2():7-10. PubMed ID: 15209867
    [No Abstract]   [Full Text] [Related]  

  • 18. ISBT Board response to the Dublin consensus statement.
    Flanagan P
    Vox Sang; 2011 Feb; 100(2):250-1. PubMed ID: 20946536
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial Contamination of Blood Products: A Neglected Subject.
    Niazi SU; Alam M; Mahmood A
    J Coll Physicians Surg Pak; 2017 Feb; 27(2):112-113. PubMed ID: 28292392
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacteriological control of preserved blood, its components and preparations].
    Pozdniakov VA; Savko LA
    Probl Gematol Pereliv Krovi; 1967 Sep; 12(9):52-4. PubMed ID: 4899963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.